Newer drugs keep multiple sclerosis patients out of wheelchairs - expert : izindaba

There are fewer multiple sclerosis (MS) patients in wheelchairs than ever before in South Africa (SA), mainly owing to the advent of interferon drugs over the past decade and better second-line drugs over the past 3 years, says Prof. Girish Modi, Head of Neurology at the University of the Witwatersrand. He was responding to claims last month by the Biokinetics Association of South Africa (BASA) that physical activity helps manage symptoms and prevent complications and can perhaps even slow progression of MS.